Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: A new role for magnetic resonance imaging

American Journal of Gastroenterology

Volumn 100, Issue 4, 2005, Pages 837-841

  Olynyk, John K ^a   St Pierre, Timothy G ^b   Britton, Robert S ^b   Brunt, Elizabeth M ^b   Bacon, Bruce R ^b  

^a FREMANTLE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IRON; FERRITIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ACCURACY; ADULT; ARTICLE; DISEASE SEVERITY; EXPOSURE; FEMALE; GENETIC DISORDER; HEMOCHROMATOSIS; HUMAN; LIVER; LIVER BIOPSY; LIVER FIBROSIS; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; AGE; BIOPSY; BLOOD; CLASSIFICATION; DISEASE COURSE; GENETICS; HOMOZYGOTE; IMAGE PROCESSING; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PILOT STUDY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK;

ADULT; AGE FACTORS; BIOPSY; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; FERRITINS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; SENSITIVITY AND SPECIFICITY;

EID: 17544370537     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.41287.x     Document Type: Article

References (28)

1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-08.
2. Olynyk JK, Cullen DJ, Aquilia S, et al. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
3. Beutler E, Felitti VJ, Koziol JA, et al. Penetrance of 845G-A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-18.
4. Harrison SA, Bacon BR. Hereditary hemochromatosis: Update for 2003. J Hepatol 2003;38(Suppl 1):S14-23.
5. Elmberg M, Hultcrantz R, Ekbom A, et al. Cancer risk in patients with hereditary hemochromatosis and their first-degree relatives. Gastroenterology 2003;125:1733-41.
6. Olynyk JK, Hagan SE, Cullen DJ, et al. Evolution of untreated hereditary hemochromatosis in the Busselton population: A 17-year study. Mayo Clin Proc 2004;79:309-13.
7. Galhenage SP, Viiala CH, Olynyk JK. Screening for hemochromatosis: Patients with liver disease, families, and populations. Curr Gastroenterol Rep 2004;6:44-51.
8. Pietrangelo A. Hereditary hemochromatosis: A new look at an old disease. N Engl J Med 2004;350:2383-97.
9. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
10. Guyader D, Jacquilinet C, Moirand R, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-36.
11. Bacon BR, Olynyk JK, Brunt EM, et al. HFE genotypes in patients with hemochromatosis and in other liver diseases. Ann Int Med 1999;130:953-62.
12. Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Int Med 2003;138:627-33.
13. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical level associated with fibrosis. Hepatology 1986;6:24-29.
14. Olynyk J, Hall P, Sallie R, et al. Computerized measurement of iron in liver biopsies: Comparison with biochemical iron measurement. Hepatology 1990;12:26-30.
15. Adams P. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis? Am J Gastroenterol 2001;96:567-69.
16. Fletcher LM, Dixon JL, Purdie DM, et al. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122:281-89.
17. Bridle KR, Crawford DHG, Fletcher LM, et al. Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis. J Hepatol 2003;38:521-25.
18. Sallie RW, Reed WD, Shilkin KB. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut 1991;32:207-10.
19. St Pierre TG, Clark PR, Chua-Anusorn W, et al. Non-invasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2004 (pre-published online July 15).
20. Leicester KL, Olynyk JK, Brunt EM, et al. CD14-positive hepatic monocytes/macrophages increase in hereditary hemochromatosis. Liver International (in press).
21. Torrance JD, Bothwell TH. Iron stores. Meth Hematol 1980;1:90-115.
22. Olynyk J, Williams P, Fudge A, et al. Fine needle aspiration liver biopsy for measurement of hepatic iron concentration. Hepatology 1992;15:502-6.
23. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-32.
24. Di Bisceglie AM. Natural history of hepatitis C: Its impact on clinical management. Hepatology 2000;31:1014-18.
25. Asberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;10:1108-15.
26. McCune CA, Al-Jader LN, May A, et al. Hereditary haemochromatosis: Only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Hum Genet 2002;111:538-43.
27. Andersen RV, Tybjaerg-Hansen A, Appleyeard M, et al. Hemochromatosis mutations in the general population: Iron overload progression rate. Blood 2004;103:2914-19.
28. Beaton M, Guyader D, Deugnier Y, et al. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002;36:673-78.